Publicacións (13) Publicacións de Victoria Nartallo Penas

2024

  1. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

    The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828

  3. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study

    Pediatric Allergy and Immunology, Vol. 35, Núm. 5

2023

  1. Adverse events in pregnant women with the tetravalent influenza vaccine obtained from cell cultures

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 420-422

  2. Adverse events in pregnant women with the tetravalent influenza vaccine obtained from cell cultures

    Enfermedades infecciosas y microbiologia clinica (English ed.), Vol. 41, Núm. 7, pp. 420-422

  3. COVID-19 vaccine effectiveness against Omicron variant in pediatric galician population

    XLI Reunión Anual de la Sociedad Española de Epidemiología (SEE) y XVIII Congresso da Associação Portuguesa de Epidemiología (APE)

  4. COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain

    Pediatric Allergy and Immunology, Vol. 34, Núm. 10

  5. Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children

    New England Journal of Medicine, Vol. 388, Núm. 5, pp. 427-438

  6. Improving Influenza Vaccine Acceptance in Children Leveraging on COVID-19 Vaccination Lessons

    Archivos de Bronconeumologia, Vol. 59, Núm. 8, pp. 531-533

2022

  1. Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain

    Environmental Research, Vol. 215

2011

  1. Cobertura vacunal en personas menores de 65 años con factores de riesgo en Galicia

    Cadernos de atención primaria, Vol. 18, Núm. 1, pp. 4-6

  2. Implementation and impact of a meningococcal C conjugate vaccination program in 13- to 25-year-old individuals in Galicia, Spain

    Journal of Public Health, Vol. 19, Núm. 5, pp. 409-415

2009

  1. A conveniencia da vacinación fronte á gripe estacional

    Cadernos de atención primaria, Vol. 16, Núm. 3, pp. 190